X4 Pharmaceuticals Depreciation & Amortization 2011-2026 | XFOR

Annual Depreciation & Amortization X4 Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.28 M	796 K	419 K	513 K	499 K	351 K	103 K	103 K	71 K	285 K	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.28 M	71 K	442 K

Quarterly Depreciation & Amortization X4 Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	476 K	-	200 K	100 K	62 K	-	-	-	127 K	-	389 K	-	133 K	-	367 K	-	106 K	-	248 K	102 K	36 K	-	71 K	44 K	20 K	-	77 K	51 K	26 K	-	148 K	96 K	48 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
476 K	20 K	139 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AbbVie ABBV	762 M	$ 208.84	-2.86 %	$ 369 B	USA
AbCellera Biologics ABCL	18.4 M	$ 3.52	0.28 %	$ 1.05 B	Canada
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	10 M	$ 3.33	-2.06 %	$ 99 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
Adaptive Biotechnologies Corporation ADPT	16 M	$ 14.81	2.63 %	$ 2.25 B	USA
Altimmune ALT	112 K	$ 3.34	7.05 %	$ 294 M	USA
Amgen AMGN	5.17 B	$ 347.94	-1.51 %	$ 187 B	USA
ANI Pharmaceuticals ANIP	67.7 M	$ 74.21	-2.3 %	$ 1.43 B	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 8.03	2.29 %	$ 220 M	Israel
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aurinia Pharmaceuticals AUPH	19.4 M	$ 15.61	0.9 %	$ 2.1 B	Canada
Autolus Therapeutics plc AUTL	8.3 M	$ 1.41	2.17 %	$ 375 M	Britain
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.68	1.52 %	$ 16.8 M	USA
Atea Pharmaceuticals AVIR	416 K	$ 5.76	1.95 %	$ 469 M	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
BioCryst Pharmaceuticals BCRX	1.25 M	$ 9.02	-3.84 %	$ 1.86 B	USA
Axcella Health AXLA	412 K	-	-16.42 %	$ 249 M	USA
Axon Enterprise AXON	48.4 M	$ 412.81	-2.54 %	$ 31.3 B	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 318.85	-3.01 %	$ 41.8 B	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel